Farmacia Hospitalaria y Farmacogenómica

Morillo Verdugo R; Calvin Lamas M; Delgado Latorre ATJ; Ferrando Piqueres R; Fernández-Llamazares CM; Negro Vega E; Tortajada Goitia B.

Development of the Q-PEX standard for quality certification of pharmaceutical care for outpatients of Pharmacy services

Journal Of Healthcare Quality Research. 2021; 36(6): 324-332 Nº de citas: 6 [doi:10.1016/j.jhqr.2021.03.010]

García-González X; Salvador-Martín S.

Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?

Journal Of Personalized Medicine. 2021; 11(11): Nº de citas: 4 [doi:10.3390/jpm11111180]

Salvador-Martin, S; Melgarejo-Ortuno, A; Lopez-Fernandez, LA.

Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease

Pharmaceutics. 2021; 13(11): Nº de citas: 4 [doi:10.3390/pharmaceutics13111786]

SALVADOR, S.; MELGAREJO, A.; LOPEZ, L..

Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease

Pharmaceutics. 2021; 13(11): [doi:https://doi.org/10.3390/pharmaceutics13111786]

GIL, S.; CARBONELL, D.; LOPEZ, L.; MIGUENS, I.; ALONSO, R.; BUÑO, I.; Muñoz, P.; Ochando Cano, Jordi; PION, M.; CORREA, R..

Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days

Frontiers in Immunology. 2021; 12: 726960-726960 Nº de citas: 18 [doi:10.3389/fimmu.2021.726960]

Amor-Garcia, MA; Fernandez-Llamazares, CM; Manrique-Rodriguez, S; Narrillos-Moraza, A; Garcia-Morin, M; Huerta-Aragones, J; Sanjurjo-Saez, M.

Bromocriptine for the treatment of postoperative cerebellar mutism syndrome in pediatric patients: Three case reports

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2021; 27(7): 1753-1757 Nº de citas: 10 [doi:10.1177/1078155220982046]

Nieto-Gonzalez, JC; Trives-Folguera, L; Melgarejo-Ortuno, A; Ais, A; Serrano-Benavente, B; Sanjurjo, M; Alvaro-Gracia, JM; Saez, IM.

Persistence and adherence to biologic therapies in juvenile idiopathic arthritis

Scientific Reports. 2021; 11(1): 16195-16195 Nº de citas: 4 [doi:10.1038/s41598-021-95252-8]

Souza-Neto, FV; Jimenez-Gonzalez, S; Delgado-Valero, B; Jurado-Lopez, R; Genty, M; Romero-Miranda, A; Rodriguez, C; Nieto, ML; Martinez-Martinez, E; Cachofeiro, V.

The Interplay of Mitochondrial Oxidative Stress and Endoplasmic Reticulum Stress in Cardiovascular Fibrosis in Obese Rats

Antioxidants. 2021; 10(8): Nº de citas: 28 [doi:10.3390/antiox10081274]

Villalvazo, P; Marzal-Alfaro, B; Garcia-Alfonso, P; Revuelta-Herrero, JL; Thomas, F; Lopez-Tarruella, S; Garcia-Gonzalez, X; Calvo, A; Yakoubi, M; Salvador-Martin, S; Lopez-Lopez, F; Aguilar, I; Sanjurjo-Saez, M; Martin, M; Lopez-Fernandez, LA.

DPYD Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach

Journal Of Personalized Medicine. 2021; 11(8): Nº de citas: 5 [doi:10.3390/jpm11080792]

Escudero-Vilaplana, V; Collado-Borrell, R; del Monte-Millan, M; Hoyo-Munoz, A; Martinez-Sagrera, PG; Revuelta-Herrero, JL; Marzal-Alfaro, B; Gonzalez-Haba, E; Cobo, SLT; Gilarranz, YJ; Herranz, A; Sanjurjo, M; Martin, M.

Assessment of diarrhea as side effect of oral targeted antineoplastic agents in clinical practice

SUPPORTIVE CARE IN CANCER. 2021; 29(8): 4673-4681 Nº de citas: 1 [doi:10.1007/s00520-021-06016-z]

Garcia-Martin, E; Escudero-Vilaplana, V; Fox, B; Collado-Borrell, R; Marzal-Alfaro, B; Sanchez-Isac, M; Solano-Garzon, ML; del Val, RG; Cano-Gonzalez, JM; de Lucas, NP; Bravo-Guillen, AI; Valero-Salinas, J; Gonzalez-Haba, E; Sanjurjo, M; Martin, M.

Aggressiveness of end-of-life cancer care: what happens in clinical practice?

SUPPORTIVE CARE IN CANCER. 2021; 29(6): 3121-3127 Nº de citas: 6 [doi:10.1007/s00520-020-05828-9]

Ibanez-Garcia, S; Zatarain-Nicolas, E; Garcia-Gonzalez, X; Rodriguez-Ferrero, ML; Fernandez-Yanez, J; Diaz, FJFA; Saez, MS.

Levels of tacrolimus after treatment for chronic hepatitis C with direct antiviral agents in solid organ transplant recipients

International Journal of Clinical Pharmacy. 2021; 43(3): 731-736 Nº de citas: 1 [doi:10.1007/s11096-020-01162-6]

Escudero-Vilaplana, V; Collado-Borrell, R; Villanueva-Bueno, C; Alvarez, R; Herranz, A; Sanjurjo, M.

Acute pancreatitis in a patient treated with imatinib and gefitinib

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2021; 27(4): 980-983 Nº de citas: 1 [doi:10.1177/1078155220949639]

Laserna-Mendieta, EJ; Salvador-Martin, S; Marin-Jimenez, I; Menchen, LA; Lopez-Cauce, B; Lopez-Fernandez, LA; Lucendo, AJ.

Comparison of a new rapid method for determination of serum anti-adalimumab and anti-infliximab antibodies with two established ELISA kits

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 2021; 198: 114003-114003 Nº de citas: 10 [doi:10.1016/j.jpba.2021.114003]

Garrido-Corro, B; Fernandez-Llamazares, CM; Rodriguez-Marrodan, B; Pozas, M; Solano-Navarro, C; Otero, MJ.

Multicentric study on the incidence and preventability of medication-related incidents in patients visiting pediatric emergency departments

FARMACIA HOSPITALARIA. 2021; 45(3): 115-120 Nº de citas: 3 [doi:10.7399/fh.11583]

Calvo-Haro, JA; Pascau, J; Asencio-Pascual, JM; Calvo-Manuel, F; Cancho-Gil, MJ; Lopez, JFD; Fanjul-Gomez, M; Garcia-Leal, R; Gonzalez-Casaurran, G; Gonzalez-Leyte, M; Leon-Luis, JA; Mediavilla-Santos, L; Ochandiano-Caicoya, S; Perez-Caballero, R; Ribed-Sanchez, A; Rio-Gomez, J; Sanchez-Perez, E; Serrano-Andreu, J; Tousidonis-Rial, M; Vaquero-Martin, J; Jose, SGS; Perez-Mananes, R.

Point-of-care manufacturing: a single university hospital's initial experience

3d Printing In Medicine. 2021; 7(1): 11-11 Nº de citas: 11 [doi:10.1186/s41205-021-00101-z]

Melgarejo-Ortuno, A; Escudero-Vilaplana, V; Revuelta, JL; Bailen, R; Collado-Borrell, R; Gomez-Centurion, I; Oarbeascoa, G; Kwon, M; Heranz, A; Diez-Martin, JL; Sanjurjo, M.

Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2021; 27(3): 751-755 Nº de citas: 7 [doi:10.1177/1078155220948934]

Martin, M; Ramos-Medina, R; Bernat, R; Garcia-Saenz, JA; del Monte-Millan, M; Alvarez, E; Cebollero, M; Moreno, F; Gonzalez-Haba, E; Bueno, O; Romero, P; Massarrah, T; Echavarria, I; Jerez, Y; Herrero, B; del Val, RG; Lobato, N; Rincon, P; Palomero, MI; Marquez-Rodas, I; Lizarraga, S; Asensio, F; Lopez-Tarruella, S.

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts

Scientific Reports. 2021; 11(1): 7064-7064 Nº de citas: 14 [doi:10.1038/s41598-021-85962-4]